Azar Signals CMS Will Not Lower Star Ratings For Drug Plans That Apply Management Tools To Protected Rx Classes

May 14, 2018
HHS Secretary Alex Azar said CMS will take a more permissive approach to the performance scores it gives drug plans that use medication management tools for drugs in Part D’s six protected classes. The Obama administration was attacked by patients, drug makers and both political parties for proposing to remove the protected status of three of those drug classes, but Azar said the Trump administration’s proposal would merely let plans take advantage of existing medication management tools that they fear...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.